PEER simplified lipid guideline 2023 update: Prevention and management of cardiovascular disease in primary care.

ABSTRACT:

Objective

To update the 2015 clinical practice guideline and provide a simplified approach to lipid management in the prevention of cardiovascular disease (CVD) for primary care.

Methods

Following the Institute of Medicine's Clinical Practice Guidelines We Can Trust, a multidisciplinary, pan-Canadian guideline panel was formed. This panel was represented by primary care providers, free from conflicts of interest with industry, and included the patient perspective. A separate scientific evidence team performed evidence reviews on statins, ezetimibe, proprotein convertase subtilisin-kexin type 9 inhibitors, fibrates, bile acid sequestrants, niacin, and omega-3 supplements (docosahexaenoic acid with eicosapentaenoic acid [EPA] or EPA ethyl ester alone [icosapent]), as we

SUBMITTER: Kolber MR 

PROVIDER: S-EPMC10575658 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature